A co-founder of 360 Life Sciences Advisors, Tom is a proven, hands-on senior executive who has transformed businesses, established new market opportunities and driven growth in the face of strong competition. His extensive leadership experience across start-up’s to larger corporate organizations helps him recognize and optimize business value. Tom understands how to promote growth by building organizational capabilities, optimizing product portfolios, developing innovative go-to-market models, and establishing processes for effective management. He helps private-equity and venture capital firms with their portfolio companies and in identifying and assessing potential medical device investment opportunities.

Tom was CEO and a member of the Board of Directors of Amniox Medical, the pioneer and leader in amniotic membrane for wound care and orthopedic surgery. He transformed Amniox implementing processes, systems and personnel changes leading to significant growth and access to new market segments. Previously Tom was President and a member of the Board of Directors of SurgiQuest, Inc., a start-up that revolutionized access management in robotic and laparoscopic surgery, which was acquired by ConMed. Tom was President, Americas of Smith & Nephew Wound Management and served on the Global Executive Management team of their $1.3 billion wound management business. He led the turnaround of the America’s business and established Smith & Nephew as a leading player in the negative pressure wound therapy market against a strong monopoly. Previously Tom served as Senior Vice President for SonoSite, the world leader in point-of-care ultrasound, where he was responsible for the US market, worldwide marketing, business development and investor relations. He drove growth in excess of 20% annually leading to SonoSite’s acquisition by Fujifilm.

Tom also served as President of InterVascular, Inc. and Corporate Vice President of Business Development at Datascope. He was the Vice President of Marketing at U.S. Surgical/Tyco Healthcare (now Covidien/Medtronic) and ran business development during a period of significant M&A activity with multiple acquisitions and divestitures that transformed the corporation. Earlier in his career, Tom held various sales, marketing and international positions of increasing responsibility with C.R. Bard, Puritan-Bennett and Johnson & Johnson.

He currently works with the Life Sciences Incubator at the Mayo Clinic to mentor leadership teams of newly formed companies. Tom served on the board of directors of Rita Medical Systems, which was acquired by AngioDynamics and various venture-backed medical device companies. He chaired the Wound Healing and Tissue Regeneration sector of AdvaMed and also served on the board of MITA, the industry trade group for medical imaging.